No herb has been proven to kill cancer in humans. Several plant compounds can destroy cancer cells in lab dishes and slow tumor growth in animals, but that is a very different thing from shrinking a tumor inside a living person. The gap between those two settings is enormous, and understanding why will help you evaluate the many claims you’ll encounter online.
What “Kills Cancer” Means in a Lab vs. in Your Body
When researchers say a plant compound “kills cancer cells,” they almost always mean it killed cells growing in a plastic dish. In that controlled environment, cells are stripped of everything that normally surrounds them: immune cells, blood vessels, connective tissue, and the complex signaling that happens between a tumor and the rest of the body. Cells also change when grown in culture, raising doubts about whether they still behave like the tissue they came from. A compound that works in a dish faces entirely different challenges inside a human body, where it must survive digestion, reach the tumor in high enough concentrations, and avoid harming healthy tissue along the way.
Animal studies get closer to real-world conditions, but results in mice frequently don’t translate to people. The doses used in animal experiments are often far higher, relative to body weight, than what a person could safely consume. And tumors implanted in lab mice don’t perfectly replicate the complexity of a cancer that developed naturally over years in a human organ.
Plant Compounds With the Most Research
Curcumin (Turmeric)
Curcumin, the yellow pigment in turmeric, is one of the most studied plant compounds in cancer research. In lab settings, it triggers cancer cell death through multiple routes: disrupting growth signals, halting cell division, and interfering with the ability of cancer stem cells to renew themselves. It has shown activity against colorectal, breast, prostate, and pancreatic cancer cells in preclinical work.
The major obstacle is absorption. Your body breaks down curcumin quickly and absorbs very little of it into the bloodstream. Researchers have tried pairing it with black pepper extract, wrapping it in fat-based delivery systems, and using nano-encapsulated formulations. These approaches do increase blood levels compared to plain curcumin powder, but even enhanced formulations still produce concentrations well below what would be needed for a therapeutic effect against tumors. Small clinical trials have explored curcumin alongside chemotherapy and radiation, but no large controlled trial has demonstrated that it improves cancer outcomes in humans.
EGCG (Green Tea)
The primary active compound in green tea can enhance the effectiveness of several standard chemotherapy drugs in laboratory experiments, making resistant cancer cells more sensitive to treatment. It also appears to reduce some chemotherapy side effects, including nausea and kidney damage, through its anti-inflammatory properties. However, like curcumin, it has low bioavailability and poor targeting once inside the body, which has limited its usefulness in clinical practice.
Sulforaphane (Broccoli Sprouts)
Sulforaphane, concentrated in broccoli sprouts and other cruciferous vegetables, has attracted attention for its ability to target cancer stem cells, the small population of cells believed to drive tumor regrowth and resistance to treatment. In one study, sulforaphane inhibited the proliferation of leukemia stem-like cells both in lab dishes and in animals by shutting down a key growth signaling pathway. This is promising in concept, but human trials confirming these effects are lacking.
Withaferin A (Ashwagandha)
Withaferin A, a compound from the ashwagandha plant, has produced some striking results in animal models. In mice with cervical cancer tumors, it reduced tumor volume by 70%. It shrank pancreatic cancer tumors by 30% to 58% depending on dose. In a breast cancer mouse model, it cut the area of invasive cancer by over 95% compared to untreated animals. It has also blocked metastasis in ovarian and breast cancer models, in one case completely preventing the spread of ovarian tumors. These numbers sound dramatic, but they come from carefully controlled animal experiments using injected doses that don’t correspond to taking an ashwagandha supplement.
Herbal Products the FDA Has Flagged
The FDA has issued warning letters to companies selling more than 80 products that illegally claim to prevent, treat, or cure cancer. These include ashwagandha supplements, graviola (soursop) capsules and teas, essiac tea, black salve, chaga mushroom extract, CBD oils in various forms, astragalus products, and many others. None of these products have been reviewed for safety or effectiveness against cancer. The companies range from small herbalists to well-known supplement brands, and most sell through websites or social media.
One particularly dangerous example is amygdalin, marketed as Laetrile or “vitamin B17” and derived from apricot kernels. It has shown no anticancer activity in human trials. In the largest study, only 1 of 175 patients showed any response, and it lasted just 10 weeks. More than half had measurable disease progression by the end of treatment. The real danger is that amygdalin breaks down into cyanide in the body, causing symptoms ranging from nausea and dizziness to liver damage, coma, and death. Eating raw almonds or certain fruits while taking it makes the toxicity worse.
Herbs That Interfere With Cancer Treatment
If you’re receiving chemotherapy, some herbs don’t just fail to help. They can actively undermine your treatment. St. John’s wort is the most well-documented offender. It reduced blood levels of the active form of one chemotherapy drug by 42%, cut the effectiveness of another by about 30%, and increased the rate at which a third was cleared from the body. In each case, less drug stayed in the bloodstream long enough to fight the cancer.
Antioxidant supplements also pose risks during treatment. In postmenopausal breast cancer survivors, using antioxidant supplements during chemotherapy or radiation was associated with increased mortality and worse recurrence-free survival. Two clinical trials found that vitamin E supplementation during treatment for head and neck cancer led to higher rates of tumor relapse and shorter cancer-free survival. These findings run counter to the intuition that antioxidants are always beneficial. During treatment, some therapies work by generating oxidative stress to kill cancer cells, and flooding the body with antioxidants may protect the very cells you’re trying to destroy.
Ginseng has been linked to liver toxicity when taken alongside certain targeted therapies. Even herbs that seem harmless can alter how your liver processes drugs, unpredictably raising or lowering medication levels in your blood.
What Integrative Oncology Actually Recommends
Major cancer organizations do not recommend any herb as a cancer treatment. The American Society of Clinical Oncology’s integrative oncology guidelines mention only one herbal product with a conditional recommendation: American ginseng for managing cancer-related fatigue during treatment. That recommendation is specifically about fatigue management, not tumor reduction.
Other herbs that have been studied in clinical trials, including mistletoe extract, did not generate enough evidence for oncology guidelines to recommend for or against their use. The overall stance of mainstream oncology is that plant compounds are worth studying in rigorous trials, but the current evidence does not support using any herb as a substitute for proven cancer treatment.
Why the Gap Between Lab Results and Reality Persists
Three problems explain why promising lab findings haven’t translated into herbal cancer cures. First, bioavailability: most plant compounds are poorly absorbed, rapidly broken down, or quickly eliminated by the body, so the concentrations that kill cancer cells in a dish never build up in human tissue. Second, complexity: a tumor inside a person is not just cancer cells. It’s a dynamic ecosystem of immune cells, blood vessels, and structural tissue that all influence how a tumor grows and responds to treatment. Lab dishes can’t replicate this. Third, dosing: the amounts needed to produce anticancer effects in animals often translate to quantities no person could safely consume through food or supplements.
Eating a diet rich in cruciferous vegetables, turmeric, and green tea is associated with lower cancer risk in population studies, but that is a story about long-term prevention through complex dietary patterns, not about any single compound killing an existing tumor. The difference between reducing risk over decades and treating active disease is fundamental, and conflating the two leads to dangerous decisions.